Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches that direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research, and to investigate the impact of directly engaging participants in decisions regarding returning of genomic results on participants' health and satisfaction. Participants in this study will be presented with the choice of types of genomic results to receive, and the Engagement Optimization Unit (EOU) will investigate the impact of this intervention on participant knowledge, expectations of benefit, personal utility, and decisional conflict.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Rozpoznanie raka żółciowego, białaczki wielomięśniowej, raka jelita grubego lub odbytnicy (dla osób czarnych poniżej 65 lat)
- •Wiek co najmniej 18 lat
- •Umiejętność zrozumienia i gotowość do podpisania dokumentu zgody
✗ Disqualifies
- •Inny typ nowotworu niż wyspecyfikowany
- •Wiek poniżej 18 lat
- •Niemożność zrozumienia warunków badania
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 14, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Washington University School of Medicine
St Louis, United States
Trial contact
Graham Colditz, M.D., DrPH, MPH
Bettina Drake, Ph.D., MPH
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/15/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.